Liver diseases are commonly diagnosed using serum enzyme assays, particularly for aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), gamma-glutamyl transpeptidase (GGT), and 5′-nucleotidase (5′-NT).
Kriya Therapeutics buys scientific advisor’s NASH gene therapy company
Shankar Ramaswamy’s Kriya Therapeutics has acquired another gene therapy startup for an undisclosed amount. Kriya has purchased Tramontane Therapeutics, a chronic liver disease gene therapy
September 7, 2023